Clinical Trial Update: TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transarterial chemoembolization with irinotecan drug-eluting beads in combination with intravenous cetuximab for refractory colorectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan drug-eluting beads (irinotecan)

Snippet

Sponsor: Hans-Joachim Schmoll, MD | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED